UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide AE37 vaccine in breast cancer patients to prevent recurrence

Annals of oncology, 2016-07, Vol.27 (7), p.1241-1248

2016

Volltextzugriff (PDF)

Tumor-infiltrating and circulating granulocytic myeloid-derived suppressor cells correlate with disease activity and adverse clinical outcomes in mycosis fungoides

Clinical & translational oncology, 2020-07, Vol.22 (7), p.1059-1066

2020

Volltextzugriff (PDF)

Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients

Schizophrenia research, 2001-01, Vol.47 (1), p.13-25

2001

Volltextzugriff (PDF)

Large-scale expansion of CD3+CD56+ lymphocytes capable of lysing autologous tumor cells with cytokine-rich supernatants

Cancer Immunology, Immunotherapy, 2002-10, Vol.51 (8), p.440-448

2002

Volltextzugriff (PDF)

Natural killer lymphocytes: biology, development, and function

Cancer Immunology, Immunotherapy, 2004-03, Vol.53 (3), p.176-186

2004

Volltextzugriff (PDF)

In Vivo Antitumor Activity of NKT Cells Activated by the Combination of IL-12 and IL-18

The Journal of immunology (1950), 2003-09, Vol.171 (6), p.2953-2959

2003

Volltextzugriff (PDF)

Peptide HER2(776-788) represents a naturally processed broad MHC class II-restricted T cell epitope

British journal of cancer, 2001-11, Vol.85 (10), p.1527-1534

2001

Volltextzugriff (PDF)

Tumor-Specific CD4+ T Lymphocytes from Cancer Patients Are Required for Optimal Induction of Cytotoxic T Cells Against the Autologous Tumor

The Journal of immunology (1950), 2000-04, Vol.164 (7), p.3902-3912

2000

Volltextzugriff (PDF)

An improved fluorescence assay for the determination of lymphocyte-mediated cytotoxicity using flow cytometry

Journal of immunological methods, 1994-12, Vol.177 (1), p.101-111

1994

Volltextzugriff (PDF)

Cytotoxic T-cell precursor frequencies to HER-2 (369 - 377) in patients with HER-2 neu-positive epithelial tumours

British journal of cancer, 2003-09, Vol.89 (6), p.1055-1061

2003

Volltextzugriff (PDF)

Immunogenic HER-2/neu peptides as tumor vaccines

Cancer Immunology, Immunotherapy, 2006-01, Vol.55 (1), p.85-95

2006

Volltextzugriff (PDF)

Pooled peptides from HER-2/neu-overexpressing primary ovarian tumours induce CTL with potent antitumour responses in vitro and in vivo

British journal of cancer, 2005-01, Vol.92 (1), p.72-79

2005

Volltextzugriff (PDF)

Immunobiology of HER-2/neu oncoprotein and its potential application in cancer immunotherapy

Cancer Immunology, Immunotherapy, 2004-03, Vol.53 (3), p.166-175

2004

Volltextzugriff (PDF)

Targeting of tumor cells by lymphocytes engineered to express chimeric receptor genes

Cancer Immunology, Immunotherapy, 2004-10, Vol.53 (10), p.893-903

2004

Volltextzugriff (PDF)

Redirecting mouse T hybridoma against human breast and ovarian carcinomas: in vivo activity against HER-2/neu expressing cancer cells

British journal of cancer, 2003-04, Vol.88 (8), p.1292-1300

2003

Volltextzugriff (PDF)

Interactions Between Human Mesenchymal Stem Cells and Natural Killer Cells

Stem cells (Dayton, Ohio), 2006-01, Vol.24 (1), p.74-85

2006

Volltextzugriff (PDF)

Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer

Cancer, 1994-08, Vol.74 (4), p.1275-1282

1994

Volltextzugriff (PDF)

POD-04.04: Phase I Clinical Study of the Novel LI-Key/HER-2(776-790) Hybrid Peptide Vaccine in Patients with Prostate Cancer

Urology (Ridgewood, N.J.), 2009, Vol.74 (4), p.S11-S11

2009

Volltextzugriff (PDF)

Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine‐activated killer cell function in patients with breast cancer

Cancer, 1993-07, Vol.72 (2), p.491-501

1993

Volltextzugriff (PDF)

Compromised anti‐tumor responses in tumor necrosis factor‐α knockout mice

European journal of immunology, 2000-07, Vol.30 (7), p.1957-1966

2000

Volltextzugriff (PDF)

Preexisting immunity as a potential biomarker for clinical response to AE37 vaccination in breast cancer patients

Annals of oncology, 2015-11, Vol.26, p.viii1-viii1

2015

Volltextzugriff (PDF)

Theophylline induces a reduction in circulating interleukin-4 and interleukin-5 in atopic asthmatics

The European respiratory journal, 1999-01, Vol.13 (1), p.53-58

1999

Volltextzugriff (PDF)

Granulocyte-macrophage colony-stimulating factor improves immunological parameters in patients with refractory solid tumours receiving second-line chemotherapy: Correlation with clinical responses

European journal of cancer (1990), 1997-07, Vol.33 (8), p.1202-1208

1997

Volltextzugriff (PDF)

Increased generation of autologous tumor-reactive lymphocytes by anti-CD3 monoclonal antibody and prothymosin α

Cancer Immunology, Immunotherapy, 1999-05, Vol.48 (2-3), p.71-84

1999

Volltextzugriff (PDF)

Beneficial effect of short-term exposure of human NK cells to IL15/IL12 and IL15/IL18 on cell apoptosis and function

Cellular Immunology, 2005-03, Vol.234 (1), p.67-75

2005

Volltextzugriff (PDF)

1 – 25 von 207

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(189)
Mit Volltextzugriff
(180)

Publikationsform

Sprache

Englisch
(206)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide AE37 vaccine in breast cancer patients to prevent recurrence

Tumor-infiltrating and circulating granulocytic myeloid-derived suppressor cells correlate with disease activity and adverse clinical outcomes in mycosis fungoides

Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients

Large-scale expansion of CD3+CD56+ lymphocytes capable of lysing autologous tumor cells with cytokine-rich supernatants

Natural killer lymphocytes: biology, development, and function

In Vivo Antitumor Activity of NKT Cells Activated by the Combination of IL-12 and IL-18

Peptide HER2(776-788) represents a naturally processed broad MHC class II-restricted T cell epitope

Tumor-Specific CD4+ T Lymphocytes from Cancer Patients Are Required for Optimal Induction of Cytotoxic T Cells Against the Autologous Tumor

An improved fluorescence assay for the determination of lymphocyte-mediated cytotoxicity using flow cytometry

Cytotoxic T-cell precursor frequencies to HER-2 (369 - 377) in patients with HER-2 neu-positive epithelial tumours

Immunogenic HER-2/neu peptides as tumor vaccines

Pooled peptides from HER-2/neu-overexpressing primary ovarian tumours induce CTL with potent antitumour responses in vitro and in vivo

Immunobiology of HER-2/neu oncoprotein and its potential application in cancer immunotherapy

Targeting of tumor cells by lymphocytes engineered to express chimeric receptor genes

Redirecting mouse T hybridoma against human breast and ovarian carcinomas: in vivo activity against HER-2/neu expressing cancer cells

Interactions Between Human Mesenchymal Stem Cells and Natural Killer Cells

Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer

POD-04.04: Phase I Clinical Study of the Novel LI-Key/HER-2(776-790) Hybrid Peptide Vaccine in Patients with Prostate Cancer

Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine‐activated killer cell function in patients with breast cancer

Compromised anti‐tumor responses in tumor necrosis factor‐α knockout mice

Preexisting immunity as a potential biomarker for clinical response to AE37 vaccination in breast cancer patients

Theophylline induces a reduction in circulating interleukin-4 and interleukin-5 in atopic asthmatics

Granulocyte-macrophage colony-stimulating factor improves immunological parameters in patients with refractory solid tumours receiving second-line chemotherapy: Correlation with clinical responses

Increased generation of autologous tumor-reactive lymphocytes by anti-CD3 monoclonal antibody and prothymosin α

Beneficial effect of short-term exposure of human NK cells to IL15/IL12 and IL15/IL18 on cell apoptosis and function

Suchergebnisse filtern